• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传筛查:规划和政策制定的概念框架。

Genetic screening: a conceptual framework for programmes and policy-making.

机构信息

Princeton University, Princeton, NJ 08544, USA.

出版信息

J Health Serv Res Policy. 2010 Apr;15(2):90-7. doi: 10.1258/jhsrp.2009.009084. Epub 2010 Feb 22.

DOI:10.1258/jhsrp.2009.009084
PMID:20176664
Abstract

OBJECTIVE

Policy-makers are faced with increasing pressures from a range of different stakeholders to introduce or expand genetic screening programmes. A shared understanding is therefore needed of the many factors influencing these complex policy decisions. Our aim was to develop a theoretical framework that highlights the multiple components and influences involved in genetic screening and the policy-making process.

METHODS

As part of a larger research programme, existing policy frameworks relating to genetic screening were identified through a review of the literature. Major themes were identified and synthesized into an overarching framework, which was further refined through discussions with key informants.

RESULTS

The framework consists of three parts. The first part conceptualizes genetic screening as an integrated public health programme. The second part describes the policy-making process at each stage in the life cycle of the programme. The third part depicts the broader context within which policy-making occurs.

CONCLUSION

This framework can support policy-makers by fostering a common understanding and facilitating dialogue with stakeholders. The framework has also been used as the conceptual foundation for the development of a more elaborate decision-guide.

摘要

目的

政策制定者面临着来自不同利益相关者的越来越多的压力,需要引入或扩大基因筛查计划。因此,需要对影响这些复杂政策决策的许多因素有一个共同的理解。我们的目的是开发一个理论框架,突出基因筛查和决策过程中涉及的多个组成部分和影响。

方法

作为一个更大的研究计划的一部分,通过文献回顾确定了与基因筛查相关的现有政策框架。确定了主要主题,并将其综合成一个总体框架,通过与主要信息提供者的讨论进一步完善了该框架。

结果

该框架由三部分组成。第一部分将基因筛查概念化为一个综合的公共卫生计划。第二部分描述了该计划生命周期中每个阶段的决策过程。第三部分描述了政策制定发生的更广泛的背景。

结论

该框架可以通过促进共同理解和促进与利益相关者的对话来支持政策制定者。该框架还被用作更详细决策指南的概念基础。

相似文献

1
Genetic screening: a conceptual framework for programmes and policy-making.遗传筛查:规划和政策制定的概念框架。
J Health Serv Res Policy. 2010 Apr;15(2):90-7. doi: 10.1258/jhsrp.2009.009084. Epub 2010 Feb 22.
2
Guiding policy decisions for genetic screening: developing a systematic and transparent approach.指导基因筛查的政策决策:制定一种系统且透明的方法。
Public Health Genomics. 2011;14(1):9-16. doi: 10.1159/000272898. Epub 2009 Dec 29.
3
Obesity prevention: a proposed framework for translating evidence into action.肥胖预防:将证据转化为行动的拟议框架
Obes Rev. 2005 Feb;6(1):23-33. doi: 10.1111/j.1467-789X.2005.00184.x.
4
Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.利用社交网络分析研究尼日利亚新疫苗引入决策过程。
Health Policy Plan. 2012 May;27 Suppl 2:ii27-38. doi: 10.1093/heapol/czs037.
5
The impact of context on evidence utilization: a framework for expert groups developing health policy recommendations.背景对证据利用的影响:为制定卫生政策建议的专家小组构建的一个框架
Soc Sci Med. 2006 Oct;63(7):1811-24. doi: 10.1016/j.socscimed.2006.04.020. Epub 2006 Jun 9.
6
Evidence-based policy-making: the implications of globally-applicable research for context-specific problem-solving in developing countries.循证决策:全球适用的研究对发展中国家因地制宜解决问题的影响。
Soc Sci Med. 2009 Nov;69(10):1539-46. doi: 10.1016/j.socscimed.2009.08.006. Epub 2009 Sep 24.
7
European micronutrient recommendations aligned: a general framework developed by EURRECA.欧洲微量营养素推荐意见一致:EURRECA 制定的通用框架。
Eur J Clin Nutr. 2010 Jun;64 Suppl 2:S2-10. doi: 10.1038/ejcn.2010.55.
8
Partnership experiences: involving decision-makers in the research process.合作经验:让决策者参与研究过程。
J Health Serv Res Policy. 2003 Oct;8 Suppl 2:26-34. doi: 10.1258/135581903322405144.
9
Policy to tackle the social determinants of health: using conceptual models to understand the policy process.应对健康的社会决定因素的政策:运用概念模型理解政策过程。
Health Policy Plan. 2008 Sep;23(5):318-27. doi: 10.1093/heapol/czn022.
10
Family pediatrics: report of the Task Force on the Family.家庭儿科学:家庭问题特别工作组报告
Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.

引用本文的文献

1
Perceptions of severity and their influence on reproductive decision-making following reproductive genetic carrier screening.生殖遗传携带者筛查后对严重程度的认知及其对生殖决策的影响。
Eur J Hum Genet. 2025 Mar;33(2):199-207. doi: 10.1038/s41431-024-01742-4. Epub 2024 Dec 6.
2
Unpacking the notion of "serious" genetic conditions: towards implementation in reproductive decision-making?剖析“严重”遗传疾病的概念:如何在生殖决策中得以应用?
Eur J Hum Genet. 2025 Mar;33(2):158-166. doi: 10.1038/s41431-024-01681-0. Epub 2024 Aug 10.
3
Attitudes of professional stakeholders towards implementation of reproductive genetic carrier screening: a systematic review.
专业利益相关者对生殖遗传携带者筛查实施的态度:系统评价。
Eur J Hum Genet. 2023 Apr;31(4):395-408. doi: 10.1038/s41431-022-01274-9. Epub 2023 Jan 12.
4
From the patient to the population: Use of genomics for population screening.从患者到人群:基因组学在人群筛查中的应用。
Front Genet. 2022 Oct 24;13:893832. doi: 10.3389/fgene.2022.893832. eCollection 2022.
5
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.风险调整后的癌症筛查与预防(RiskAP):通过基于风险因素的学习型筛查补充早期疾病检测筛查
Breast Care (Basel). 2022 Apr;17(2):208-223. doi: 10.1159/000517182. Epub 2021 Aug 12.
6
Ethics of Reproductive Genetic Carrier Screening: From the Clinic to the Population.生殖遗传携带者筛查的伦理:从临床到人群
Public Health Ethics. 2021 Jun 14;14(2):202-217. doi: 10.1093/phe/phab017. eCollection 2021 Jul.
7
Ethical considerations in gene selection for reproductive carrier screening.用于生殖载体筛查的基因选择中的伦理考虑因素。
Hum Genet. 2022 May;141(5):1003-1012. doi: 10.1007/s00439-021-02341-9. Epub 2021 Aug 23.
8
Expanded Neonatal Bloodspot Screening Programmes: An Evaluation Framework to Discuss New Conditions With Stakeholders.扩大新生儿血斑筛查项目:与利益相关者讨论新疾病的评估框架。
Front Pediatr. 2021 Feb 22;9:635353. doi: 10.3389/fped.2021.635353. eCollection 2021.
9
Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide.罕见病的新生儿筛查和携带者筛查:创新如何在全球范围内挑战筛查标准。
J Community Genet. 2021 Apr;12(2):257-265. doi: 10.1007/s12687-020-00488-y. Epub 2020 Oct 19.
10
How is genetic testing evaluated? A systematic review of the literature.遗传检测如何评估?文献系统评价。
Eur J Hum Genet. 2018 May;26(5):605-615. doi: 10.1038/s41431-018-0095-5. Epub 2018 Feb 8.